ACE2 and COVID-19: Moreover, we believe that is the first report, in any cell type, demonstrating that IAV modifies both ACE2 and TMPRSS2 mRNA expression and post-transcriptional regulation in a manner consistent with priming for more severe COVID-19 manifestations.